Scientific Programme
Preliminary programme and confirmed speakers
MONDAY 24th August 2020
Welcome
Diagnosis, risk factors and prognosis of TIA and minor stroke
-
Diagnosis, significance, and management of blood pressure variability in cerebrovascular diseases
TBC -
Long term risks of vascular events and management after TIA and minor stroke
TBC -
New perspectives in imaging of transient ischaemia
TBC
Prehospital management of acute ischemic stroke :
-
Mobile Stroke unit : Effects on process indicators, outcomes and cost utility
Heinrich Audebert (Berlin) -
Debate : mother ship vs drip and ship
TBC-
Utility of prehospital score to predict large artery disease
Guillaume Turc (Paris)
-
Place of geographic modelling of best transport option for treatment of acute ischemic stroke
Ludwig Schlemm (London) -
Is there a need for randomized trials ?
Natalia Pérez de la Ossa (Barcelone)
Richard Macrez (Caen)
-
TUESDAY 25th August 2020
New perspectives in endovascular treatment
-
Interventional vascular medicine with robotic assistance (Robocath)
Philippe Bencteux (Rouen) -
Automated core-penumbra quantification in acute ischemic stroke : principles and different tools
TBC -
Best strategies for endovascular treatment (combined devices of aspiration and stent retriever: update of evidence and current trials
Bertrand Lapergue (Paris) -
Mechanical thrombectomy in minor stroke and very severe stroke
Urs Fischer (Bern)
IV thrombolytic agents
-
Treatment with IV thrombolysis over 4.5h after stroke onset: how many patients in practice ? How could we implement this in routine ?
Didier Leys (Lille) -
When tenectepalse should be preferred over alteplase ?
Daniel Strbian (Helsinki) -
Molecular imaging of clots to predict therapeutic response
Maxime Gauberti (Caen) -
How to improve the thrombolytic effect of alteplase and to reduce the risk of bleeding, alteplase mutants ?
Denis Vivien (Caen) -
New antithrombotic targets: antiGP6, antiGP1, von Willebrand
Sara Martinez de Lizarrondo (Caen)
WEDNESDAY 26th August 2020
Genetics of stroke :
-
How to interpret SNP, GWAS (with examples in stroke diseases)
Stéphanie Debette (Bordeaux) -
Omics techniques
Martin Dichgans (Munich) -
New approaches in gene and cellular therapies (CRISPr)
TBC -
Ethical issues in molecular diagnostic of inherited cerebrovascular disorders » (with examples of stroke diseases)
Elisabeth Tournier-Lasserve (Paris)
Small vessel diseases
-
Small vessel diseases: pathophysiology, classification, genetics
Eric Jouvent (Paris) -
Animal models of small vessel diseases
Anne Joutel (Paris) -
Cerebral vasculitis
TBC -
Cerebral amyloid angiopathy
TBC
Meeting of the executive committee on Wednesday afternoon
THURSDAY 27th August 2020
Heart and stroke
-
Imaging of sporadic haemorrhagic cerebral microangiopathies
Grégoire Boulouis (Paris) -
Whether to resume or not antithrombotic therapies after intracerebral haemorrhage
TBC -
Indications and complications of left appendage closure in stroke patients with atrial fibrillation
TBC -
Patent foramen ovale closure in patients not included in trials: TIA patients, age > 60 years, delay from stroke > 6 months-1 year
TBC -
Place of implantable cardiac monitors in cryptogenic stroke ?
TBC
Neurosurgery in stroke
-
Hemicraniectomy for ischaemic and haemorrhagic stroke
Bart van der Worp (Utrecht) -
Local thrombolytic therapies in intraventricular haemorrhage: rationale, update of recent and future trials
TBC
FRIDAY 28th August 2020
Workshop in the laboratory
-
Visit of a pre-clinical laboratory, animal and in vitro models of aneurysm, ischaemic stroke and haemorrhagic stroke
Statistical analyses for dummies
-
Interpretation of trials outcomes (OR, RR, HR)
-
Subgroup analyses
-
Meta-analyses
-
Interim analyses